Long-persisting SARS-CoV-2 spike-specific CD4+ T cells associated with mild disease and increased cytotoxicity post COVID-19

长期存在的SARS-CoV-2刺突蛋白特异性CD4+ T细胞与COVID-19后轻症和细胞毒性增强相关

阅读:2
作者:Guihai Liu #,Elie Antoun #,Anastasia Fries,Xuan Yao,Zixi Yin,Danning Dong,Wenbo Wang,Peter A C Wing,Wanwisa Dejnirattisa,Piyada Supasa,Chang Liu,Timothy Rostron,Craig Waugh,Kevin Clark,Paul Sopp,Jeremy W Fry,Iolanda Vendrell,Jane A McKeating,Juthathip Mongkolsapaya,Gavin R Screaton,Benedikt M Kessler,Roman Fisher,Graham Ogg,Alexander J Mentzer,Julian C Knight,Yanchun Peng,Tao Dong

Abstract

The recent COVID-19 pandemic left behind the lingering question as whether new variants of concern might cause further waves of infection. Thus, it is important to investigate the long-term protection gained via vaccination or exposure to the SARS-CoV-2 virus. Here we compare the evolution of memory T-cell responses following primary infection with subsequent antigen exposures. Single-cell TCR analysis of three dominant SARS-CoV-2 spike-specific CD4+ T-cell responses identifies the dominant public TCRα clonotypes pairing with diverse TCRβ clonotypes that associated with mild disease at primary infection. These clonotypes are found at higher frequencies in pre-pandemic repertoires compared to other epitope-specific clonotypes. Longitudinal transcriptomics and TCR analysis, combined with functional evaluation, reveals that the clonotypes persisting 3-4 years post initial infection exhibit distinct functionality compared to those that were lost. Furthermore, spike-specific CD4+ T cells at this time point show decreased Th1 signatures and enhanced GZMA-driven cytotoxic transcriptomic profiles that were independent of TCR clonotype and associated with viral suppression. In summary, we identify common public TCRs used by immunodominant spike-specific memory CD4+ T-cells, associated with mild disease outcome, which likely play important protective roles to subsequent viral infection events.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。